Range Cancer Therapeutics ETF

NYSE
CNCR
ETF
Yield per half year: -22.91%
Commission: 0.79%
Industry: Global Equities
No data yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe